• Mashup Score: 0

    Due to the COVID-19 pandemic, the Transcatheter Cardiovascular Therapeutics meeting was held virtually. TCT Connect, which ran from Oct. 14 to 18, offered the latest in cutting-edge science for interventional cardiologists.Healio and Cardiology Today asked experts for their opinions on key presentations. Weighing in were Cardiology Today Editorial Board Member Anita W. Asgar, MD, MSc, FRCPC,

    Tweet Tweets with this article
    • ICYMI: Due to the #COVID_19 pandemic, the @TCTConference was held virtually from Oct. 14 to 18, and offered the latest in cutting-edge science for interventional cardiologists #TCTConnect #TCT2020 #cardiotwitter @drmortkern @Drroxmehran @SrihariNaiduMD https://t.co/Wvd9Pmz4Ra

  • Mashup Score: 0

    Due to the COVID-19 pandemic, the Transcatheter Cardiovascular Therapeutics meeting was held virtually. TCT Connect, which ran from Oct. 14 to 18, offered the latest in cutting-edge science for interventional cardiologists.Healio and Cardiology Today asked experts for their opinions on key presentations. Weighing in were Cardiology Today Editorial Board Member Anita W. Asgar, MD, MSc, FRCPC,

    Tweet Tweets with this article
    • ICYMI: Due to the #COVID_19 pandemic, the @TCTConference was held virtually from Oct. 14 to 18, and offered the latest in cutting-edge science for interventional cardiologists #TCTConnect #TCT2020 #cardiotwitter @drmortkern @Drroxmehran @SrihariNaiduMD https://t.co/Wvd9Pmz4Ra

  • Mashup Score: 3

    Due to the COVID-19 pandemic, the Transcatheter Cardiovascular Therapeutics meeting was held virtually. TCT Connect, which ran from Oct. 14 to 18, offered the latest in cutting-edge science for interventional cardiologists.Healio and Cardiology Today asked experts for their opinions on key presentations. Weighing in were Cardiology Today Editorial Board Member Anita W. Asgar, MD, MSc, FRCPC,

    Tweet Tweets with this article
    • Due to the #COVID_19 pandemic, the @TCTConference was held virtually from Oct. 14 to 18, and offered the latest in cutting-edge science for interventional cardiologists #TCTConnect #TCT2020 #cardiotwitter @drmortkern @Drroxmehran @SrihariNaiduMD https://t.co/Wvd9Pmz4Ra

  • Mashup Score: 2

    The Cardiovascular Research Foundation is a nonprofit dedicated to helping doctors improve survival and quality of life for people suffering from heart disease.

    Tweet Tweets with this article
    • Why extend access to #TCTConnect? “By extending free access to TCT Connect for one year, we hope to share the latest updates in research, training, and innovation presented at TCT with a larger, more diverse audience.” #TCT2020 https://t.co/jwwbsQ0EDW @jgranadacrf https://t.co/XSarl9htqd

  • Mashup Score: 1

    Cardiology magazine, ACC’s member publication, focuses on hot topics in the field, profiles of influential and rising star members, and putting the spotlight on facilities or practices that are doing work that represents the ACC’s mission.

    Tweet Tweets with this article
    • .@chadialraies shares his top 5️⃣ takeaways from #TCT2020 in this month’s #CardiologyMag. Also check out a roundup of hottest trials addressing #TAVR and structural #heartdisease. Read the issue here: https://t.co/WkcGIkN7zB #ACCIC https://t.co/wUSux5ODAR

  • Mashup Score: 0

    Dean Kereiakes, M.D., medical director, The Christ Hospital Heart and Vascular Center, medical director, The Christ Hospital Research Institute, and professor of clinical medicine at The Ohio State University, explains the late-breaking OPTIMIZE Trial at the 2020 Transcatheter Cardiovascular Therapeutics (T

    Tweet Tweets with this article
    • VIDEO: Results of the OPTIMIZE IDE Trial for the Svelte Drug Eluting Stent - interview with Dean Kereiakes, MD https://t.co/i53rJAigBx He explains the late-breaking OPTIMIZE Trial at the TCT 2020 #Cardiotwitter #PCI #TCT #TCTconnect #TCT2020 https://t.co/Nviq8PKnp3